No serious adverse events (SAEs) or dose-limiting toxicities were reported, and there were no signals of infection or liver enzyme elevation. These results allowed VENX-201 to advance into Phase 2 proof-of-concept studies.
Contact the experts at Pronto Arigato for your Mac or Windows PC repair today.
No serious adverse events (SAEs) or dose-limiting toxicities were reported, and there were no signals of infection or liver enzyme elevation. These results allowed VENX-201 to advance into Phase 2 proof-of-concept studies.
Copyright © Pronto Arigato LLP | UEN: T17LL0544D | All Rights Reserved | Privacy Policy | Terms & Conditions | Terms of Service
Webbo Web Design